Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Nygren

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Cancer Research|April 23, 2009
Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatinTrevor Hay, James R Matthews, Lucie Pietzka, et al.
ESMO Open|October 12, 2017
Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practiceJames L Sherwood, Helen Brown, Alessandro Rettino, et al.
Cancer Research|February 11, 2010
Sensitivity and acquired resistance of BRCA1;p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecanSerge A L Zander, Ariena Kersbergen, Eline van der Burg, et al.
European Journal of Human Genetics : EJHG|July 22, 2010
Hemizygous deletion of COL3A1, COL5A2, and MSTN causes a complex phenotype with aortic dissection: a lesson for and from true haploinsufficiencyJanine Meienberg, Marianne Rohrbach, Stefan Neuenschwander, et al.
British Journal of Cancer|November 1, 2007
Sequential gene promoter methylation during HPV-induced cervical carcinogenesisF E Henken, S M Wilting, R M Overmeer, et al.
Neurology|October 13, 2006
High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegiaC Beetz, A O H Nygren, J Schickel, et al.
European Journal of Human Genetics : EJHG|September 27, 2007
A multi-exonic SPG4 duplication underlies sex-dependent penetrance of hereditary spastic paraplegia in a large Brazilian pedigreeMiguel Mitne-Neto, Fernando Kok, Christian Beetz, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2007
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancerSven Rottenberg, Anders O H Nygren, Marina Pajic, et al.
Human Mutation|March 9, 2007
Linkage to a known gene but no mutation identified: comprehensive reanalysis of SPG4 HSP pedigrees reveals large deletions as the sole causeChristian Beetz, Stephan Zuchner, Allison Ashley-Koch, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2008
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugsSven Rottenberg, Janneke E Jaspers, Ariena Kersbergen, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Cancer Research|April 23, 2009
Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatinTrevor Hay, James R Matthews, Lucie Pietzka, et al.
ESMO Open|October 12, 2017
Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practiceJames L Sherwood, Helen Brown, Alessandro Rettino, et al.
Cancer Research|February 11, 2010
Sensitivity and acquired resistance of BRCA1;p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecanSerge A L Zander, Ariena Kersbergen, Eline van der Burg, et al.
European Journal of Human Genetics : EJHG|July 22, 2010
Hemizygous deletion of COL3A1, COL5A2, and MSTN causes a complex phenotype with aortic dissection: a lesson for and from true haploinsufficiencyJanine Meienberg, Marianne Rohrbach, Stefan Neuenschwander, et al.
British Journal of Cancer|November 1, 2007
Sequential gene promoter methylation during HPV-induced cervical carcinogenesisF E Henken, S M Wilting, R M Overmeer, et al.
Neurology|October 13, 2006
High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegiaC Beetz, A O H Nygren, J Schickel, et al.
European Journal of Human Genetics : EJHG|September 27, 2007
A multi-exonic SPG4 duplication underlies sex-dependent penetrance of hereditary spastic paraplegia in a large Brazilian pedigreeMiguel Mitne-Neto, Fernando Kok, Christian Beetz, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2007
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancerSven Rottenberg, Anders O H Nygren, Marina Pajic, et al.
Human Mutation|March 9, 2007
Linkage to a known gene but no mutation identified: comprehensive reanalysis of SPG4 HSP pedigrees reveals large deletions as the sole causeChristian Beetz, Stephan Zuchner, Allison Ashley-Koch, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2008
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugsSven Rottenberg, Janneke E Jaspers, Ariena Kersbergen, et al.
Pageof 15